(Q56901334)

English

Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action

No description defined

In more languages

Statements

scholarly article

0 references

Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

Amir Sharabi

1

0 references

Hava Azulai

2

0 references

Zev M Sthoeger

3

0 references

Edna Mozes

4

0 references

language of work or name

0 references

publication date

June 2007

0 references

0 references

121

0 references

2

0 references

248-57

0 references

Treatment of severe proliferative lupus nephritis: the current state

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

Regulatory T cells in autoimmmunity*.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265932

2 November 2018

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02565.X

21 January 2018

Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Murine lupus nephritis: effects of cyclophosphamide on circulating and tissue bound immunoreactants

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of murine lupus nephritis with cyclophosphamide or total lymphoid irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of spontaneous murine lupus by inducing graft-versus-host reaction with CD8+ cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective suppression of resting B cell function in patients with systemic lupus erythematosus treated with cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-regulation of stromal cell-derived factor-1alpha-induced T cell chemotaxis by a peptide based on the complementarity-determining region 1 of an anti-DNA autoantibody via up-regulation of TGF-beta secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The inhibition of autoreactive T cell functions by a peptide based on the CDR1 of an anti-DNA autoantibody is via TGF-beta-mediated suppression of LFA-1 and CD44 expression and function

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17346282

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2567.2007.02565.X

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56901334&oldid=1476107400"